ELANElanco Animal Health Incorporated

Healthcare

$22.92+19% 1Y

$22.92

$18.5452 weeks$26.84

Price

+19%1Y

End-of-day closes, not the intraday tick.

A mixed picture: the questions disagree

Quality mixed, nothing alarming, demanding price, growing in the filings, the market undecided.

RyuScore 40 of 100: see how it is built

What they do

Elanco Animal Health Incorporated and its subsidiaries (collectively, Elanco, the Company, we, us, or our) is a global leader in animal health, dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets. We partner with farmers, pet owners, veterinarians and society to create value and help our customers improve the health of animals in their care, while also making a meaningful impact on the communities we serve.

In the company’s own words · 10-K filed Feb 24, 2026 · SEC EDGAR

P/En/a

Market value$12.17B

1 year+19%

5 years-30%

Charts

As reported to the SEC, without any scoring.

Elanco Animal Health Incorporated (ELAN) reported revenue of $1.37B in Q2 2026 (quarter ended Jun 30, 2026), up 10% from the same quarter a year earlier. That came with a gross margin of 58% and net income of $54M (3.9% of revenue). For the full year FY2025, revenue was $4.71B (+6.2% year on year) and net income −$232M. Its largest product in Q2 2026 was Farm Animal at $633M, 49% of the disclosed total, well ahead of Cattle at 24%. The next results filing is expected around Nov 4, 2026, the same week as a year ago.

What the company said

The company's own words from its current reports to the SEC, newest first

Aug 5, 2026Elanco Animal Health Reports Second Quarter 2026 Results.Earnings release · press release
May 6, 2026Elanco Animal Health Reports First Quarter 2026 Results.Earnings release · press release
Feb 24, 2026Elanco Animal Health Reports Fourth Quarter and Full Year 2025 Results.Earnings release · press release